Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes

BACKGROUND: Activated clotting time (ACT)–guided heparinization is used during atrial fibrillation (AF) ablation. Differences in sensitivity to ACT assays have been identified among different direct oral anticoagulants (DOACs). OBJECTIVE: We aimed to examine ACT just before ablation (pre‐ACT) for di...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaji, Hirosuke, Murakami, Takashi, Hina, Kazuyoshi, Higashiya, Shunich, Kawamura, Hiroshi, Murakami, Masaaki, Kamikawa, Shigeshi, Hirohata, Satoshi, Kusachi, Shozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916399/
https://www.ncbi.nlm.nih.gov/pubmed/31701593
http://dx.doi.org/10.1111/jce.14260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916399/
https://www.ncbi.nlm.nih.gov/pubmed/31701593
http://dx.doi.org/10.1111/jce.14260

Ejemplares similares